CM
PACB icon

Caption Management’s Pacific Biosciences PACB Stock Holding History

Caption Management’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-6,400
Closed -$12.9K – 1415
2024
Q1 		$24K Sell
6,400
-45,273
-88% -$265K ﹤0.01% 1106
2023
Q4 		$507K Sell
51,673
-91,275
-64% -$746K 0.01% 964
2023
Q3 		$1.19M Buy
+142,948
New +$1.63M 0.02% 725
2021
Q3 		– Sell
-19,700
Closed -$584K – 1717
2021
Q2 		$688K Buy
+19,700
New +$573K 0.01% 982
2019
Q4 		– Sell
-69,000
Closed -$356K – 960
2019
Q3 		$356K Buy
+69,000
New +$386K 0.02% 533

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Caption Management's PACB Position: Q2 2024 in Review

Caption Management sold out of Pacific Biosciences (PACB) in Q2 2024, closing a stake of 6,400 shares — an estimated $12.9K sold.

Caption Management first reported a position in PACB in Q3 2019 and held it in 5 quarters. The position peaked at $1.19M in Q3 2023. 228 funds tracked by Wall St. Rank hold PACB as of Q2 2024.

  • Caption Management reported no remaining Pacific Biosciences position as of Q2 2024 after selling out during the quarter.
  • Caption Management sold 6,400 Pacific Biosciences shares in Q2 2024, an estimated $12.9K.
  • Caption Management first reported a position in Pacific Biosciences in Q3 2019 and held it in 5 quarters.
  • Caption Management's Pacific Biosciences position peaked at $1.19M in Q3 2023.
  • 228 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2024.

Based on Caption Management's 13F filing for Q2 2024, filed 14 Aug 2024.